Pfizer's Trading Volume Drops 27.85% to $1.137 Billion, Stock Price Rises 1.48% to 69th in Daily Ranking
Generated by AI AgentAinvest Market Brief
Friday, Apr 11, 2025 7:30 pm ET1min read
PFE--
On April 11, 2025, Pfizer's trading volume reached $1.137 billion, marking a 27.85% decrease from the previous day. The company's stock price rose by 1.48%, placing it at the 69th position in terms of trading volume for the day.
Pfizer has announced that its 2025 Annual Meeting of Shareholders will be held virtually on April 24, 2025, at 9:00 a.m. EDT. This virtual meeting is open to all shareholders and the general public, providing an opportunity for stakeholders to engage with the company's leadership and gain insights into its strategic direction and performance.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet